Discover Hope:
Welcome to Your Resource
on Multiple Sclerosis (MS)
Multiple Sclerosis (MS) remains a challenge for many, manifesting as a silent and often invisible disease. Despite the absence of a cure, there's hope through treatments aimed at speeding recovery and improving symptom management. This page is dedicated to providing comprehensive information about MS and inviting you to explore clinical studies that may offer new possibilities for managing this condition.
What is
Multiple Sclerosis?
Multiple Sclerosis is a chronic autoimmune disorder affecting the central nervous system, where the immune system erroneously attacks the myelin sheath protecting nerve fibers. This attack leads to damaged communication lines between the brain and the body, manifesting in a range of symptoms from mild to severe, potentially impacting mobility and daily functioning.
Understanding and Managing Multiple Sclerosis (MS)
Types of Multiple Sclerosis
Clinically Isolated Syndrome (CIS)
Relapsing-Remitting
MS (RRMS)
Secondary Progressive MS (SPMS)
Primary Progressive
MS (PPMS)
A first episode of symptoms lasting at least 24 hours,
indicating potential MS development.
Characterized by episodes of
new symptoms followed by periods of remission. Approximately 85% of MS diagnoses are RRMS.
A progression from RRMS,
where symptoms worsen over time, with or without active relapses.
From the onset, symptoms gradually worsen without
early relapses or remissions, affecting about 15% of MS patients.
Common Symptoms of MS
MS symptoms can vary widely, but common ones include:
Numbness or weakness in one or more limbs
Difficulty walking
Tingling sensations
Coordination problems
Partial or complete vision loss
Sexual, bowel, and bladder function issues
Vertigo
Fatigue
Cognitive challenges
Slurred speech
Mood disturbances
MS by the Numbers
01
Nearly 1 million people in the U.S. live with MS.
02
MS incidence is higher further from the equator, with Scotland reporting the highest rates.
03
Women are twice as likely as men to develop MS.
04
Over 42% of MS patients initially receive a misdiagnosis.
Treatment Options
The FDA has approved numerous disease-modifying treatments, especially for relapsing MS. Ongoing research worldwide continues to seek out new therapies, offering hope for all types of MS.
Seeking Participants for Clinical Studies
Are you interested in advancing MS research and exploring
new treatment options? Consider joining a clinical study:
Eligibility Criteria:
Ages 18-50
Diagnosed with Relapsing MS within the last 10 years
Currently on no or no more than one immunomodulatory medication
Study Benefits:
Transportation provided
No insurance required
Compensation: $50 per visit,
up to $300 upon completion
7 visits over 34 weeks
Let's take a step forward together in managing MS.
For more information and to express your interest in participating in a clinical study,
please fill out the form below. Together, we can explore new horizons in MS care and treatment.
Your journey towards a better understanding and management of MS starts here.
Explore, inquire, and join us in the pursuit of advancing MS research and treatment options.
Join Us in the
Fight Against MS
Your participation in clinical studies could light the path to groundbreaking treatments and a better understanding of MS.
If you're between 18 and 50 years old and have been diagnosed with Relapsing MS in the last decade, you might be eligible to join a study aimed at exploring innovative treatment options.
